AVA-ADR-001

N/A

Report date: 2023/08/24 13:55:18
NME

Base Information

Drug NameAVA-ADR-001
Drug Alias NameAVA-ADR-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine deaminase inhibitors
TargetsAdenosine deaminase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvammune Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAvammune Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A